Cannabis Bioscience International Holdings (CBIH) Return on Sales (2022 - 2026)

Cannabis Bioscience International Holdings has disclosed Return on Sales across 5 years of filings, most recently posting 0.09% for Q1 2026.

• Return on Sales for Q1 2026 came in at 0.09%, up 1.0% year-over-year; the trailing twelve-month figure through Feb 2026 was 0.04% (down 3.0% YoY), and the FY2025 annual result was 0.02%, changed 0.0% from the prior year.
• Return on Sales came in at 0.09% for Q1 2026 at Cannabis Bioscience International Holdings, down from 0.02% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.0% in Q2 2024 to a low of 0.1% in Q1 2025.
• The 5-year median for Return on Sales is 0.03% (2025), against an average of 0.04%.
• Across the five-year window, Return on Sales climbed 6 bps in 2024 and dropped 7 bps in 2025, its largest moves.
• Cannabis Bioscience International Holdings' Return on Sales stood at 0.03% in 2022, then soared by 44 bps to 0.01% in 2023, then surged by 38 bps to 0.01% in 2024, then plunged by 102 bps to 0.02% in 2025, then slumped by 399 bps to 0.09% in 2026.
• The last three Return on Sales figures came in at 0.09% (Q1 2026), 0.02% (Q4 2025), and 0.04% (Q3 2025), per Business Quant data.